Regeneron Pharmaceuticals
REGN
593,74 €
Share price
-2.84%
Change (1 day)
-33.23%
Change (1 year)
Categories
Market capitalization of Regeneron Pharmaceuticals (REGN)
Market cap: €64.91 Billion
As of March 2025 Regeneron Pharmaceuticals has a market cap of €64.91 Billion. This makes Regeneron Pharmaceuticals the world's 280th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Regeneron Pharmaceuticals from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €64.91 B | -13.72% |
| 2024 | €75.23 B | -13.09% |
| 2023 | €86.55 B | 18.17% |
| 2022 | €73.24 B | 22.14% |
| 2021 | €59.96 B | 43.09% |
| 2020 | €41.91 B | 13.39% |
| 2019 | €36.96 B | 3.86% |
| 2018 | €35.58 B | 5.72% |
| 2017 | €33.66 B | -8.54% |
| 2016 | €36.80 B | -29.16% |
| 2015 | €51.95 B | 50.38% |
| 2014 | €34.55 B | 73.91% |
| 2013 | €19.86 B | 57.9% |
| 2012 | €12.58 B | 218.43% |
| 2011 | €3.95 B | 79.03% |
| 2010 | €2.20 B | 61.24% |
| 2009 | €1.36 B | 30.86% |
| 2008 | €1.04 B | -19.8% |
| 2007 | €1.30 B | 31.11% |
| 2006 | €0.99 B | 31.32% |
| 2005 | €0.75 B | 99.74% |
| 2004 | €0.37 B | -41.58% |
| 2003 | €0.64 B | -17.62% |
| 2002 | €0.78 B | -43.79% |
| 2001 | €1.40 B | 1.78% |
| 2000 | €1.37 B | 245.94% |
| 1999 | €0.39 B | 106.54% |
| 1998 | €0.19 B | -13.61% |
| 1997 | €0.22 B | -36.05% |
| 1996 | €0.34 B |
End of Day market cap according to different sources
On Mar 24th, 2025 the market cap of Regeneron Pharmaceuticals was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | €151.49 B | 133.39% | 🇺🇸 USA |
 | €33.78 B | -47.95% | 🇺🇸 USA |
 | €18.95 B | -70.80% | 🇺🇸 USA |
 | €359.98 B | 454.59% | 🇺🇸 USA |
 | €201.97 B | 211.16% | 🇨🇭 Switzerland |
 | €129.36 B | 99.29% | 🇫🇷 France |